The Biliary HCO3 − Umbrella: A Unifying Hypothesis on Pathogenetic and Therapeutic Aspects of Fibrosing Cholangiopathies

Beuers, Ulrich, Hohenester, Simon, de Buy Wenniger, Lucas J. Maillette, Kremer, Andreas E., Jansen, Peter L. M., Elferink, Ronald P. J. Oude·2010·Hepatology
DOI 10.1002/hep.23810

Cited by (350)

Items 301–350 of 350

  1. Pathophysiologic Basis for Alternative Therapies for Cholestasis
    Claudia Daniela Fuchs, Emina Halilbasic, Michael A Trauner · 2020 · Wiley eBooks
  2. CHOLESTASIS: MOLECULAR MECHANISM, PATHOGENESIS AND POSSIBLE MANAGEMENT
    Basant M. Al-Botaty · 2018 · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences
  3. The Latest on Intrahepatic Cholestasis of Pregnancy – Update 2026
    Stanisƚaw Jurk, Andreas Emanuel Kremer, Ekkehard Schleußner · 2026 · Geburtshilfe und Frauenheilkunde
  4. Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
    Anne‐Christin Beatrice Wilde, Lena Maria Greverath, Lara Marleen Steinhagen, Nina Wald de Chamorro, E Leicht, Janett Fischer, Toni Herta, Thomas Berg, Beate E. Preuß, Reinhild Klein et al. · 2022 · Journal of Clinical Medicine
  5. Primary Sclerosing Cholangitis: A Clinical Update
    Sridhar Sundaram, Vaneet Jearth · 2019 · European Medical Journal
  6. Recomendaciones y criterios de calidad para mejorar el diagnóstico precoz de la colangitis biliar primaria
    Álvaro Díaz‐González, Noelia Fontanillas, Eva Gil-Hernández, Mercedes Guilabert, María‐Carlota Londoño, Mar Noguerol, Fernando Pérez Escanilla, José Joaquín Mira, Manel Santiñà · 2023 · Gastroenterología y Hepatología
  7. Chronische cholestatische Leberkrankheiten
    Simon D. Hohenester, Ulrich H. Beuers · 2017 · Der Internist
  8. Primary Biliary Cholangitis in Motion Meeting
    Lois Skellon · 2018 · EMJ Hepatology
  9. Bad memories from the gut may cause nightmares for the bile ducts
    Peter Fickert · 2016 · Journal of Hepatology
  10. Bile acids and their receptors
    Thierry Claudel, Michael A Trauner · 2015
  11. Primary Sclerosing Cholangitis (PSC)
    Harald Hofer, Emina Halilbasic, Katharina Staufer, Michael Trauner · 2013 · Springer eBooks
  12. Orphan drugs in development for primary biliary cirrhosis: challenges and progress
    Keith D. Lindor, Ahmad Hassan Ali, Thomas Byrne · 2015 · Orphan Drugs Research and Reviews
  13. Cystic Fibrosis and the gastro-intestinal tract
    Marjan Wouthuyzen‐Bakker · 2011 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  14. Liver Regeneration
    Debolina Ray, Yuyan Han, Luca Maroni, Marco Marzioni, Fanyin Meng, Gianfranco D. Alpini, Shannon S. Glaser · 2015 · Elsevier eBooks
  15. 940 LOSS OF KERATIN 19 PREDISPOSES TO THE DEVELOPMENT OF CHOLESTATIC LIVER DISEASE
    Yang Chen, Nurdan Güldiken, M. Bishr Omary, Johannes Haybäck, Pavel Strnad · 2012 · Journal of Hepatology
  16. Bile acid receptors as targets for drug
    G. Schaap, Michael A Trauner, Peter L. M. Jansen · 2013
  17. Bile Acids and Cholestatic Liver Disease 2: Primary Sclerosing Cholangitis
    Takahiro Nakazawa · 2017 · Springer eBooks
  18. Bile Acids and Cholestatic Liver Disease 1: Primary Biliary Cholangitis (PBC)
    Atsushi Tanaka · 2017 · Springer eBooks
  19. Bicarbonate Umbrella and Its Distribution of the Bile Duct
    Shinji Shimoda · 2017 · Springer eBooks
  20. Bile Acids and FGF19 in the Remission of Type 2 Diabetes After Sleeve Gastrectomy and Gastric Bypass
    Reza Nemati · 2017 · Tuwhera (Auckland University of Technology)
  21. The current issue of JHEP Reports
    Sven Francque · 2019 · JHEP Reports
  22. Gradual Rewarming Preservation of Liver and Kidney Grafts
    Paria Mahboub · 2019
  23. Cholangiocyte Biology and Pathobiology
    Massimiliano Cadamuro, Romina Fiorotto, Mario Strazzabosco · 2020 · Wiley eBooks
  24. Bile Acids and Bilirubin in Liver Immunology
    Ci Zhu, Thierry Claudel, Michael Trauner · 2020 · Springer eBooks
  25. The revival of preemptive UDCA therapy in liver transplant recipients
    Christophe Corpechot · 2021 · Clinics and Research in Hepatology and Gastroenterology
  26. Pleiotropic effects of ursodeoxycholic acid
    Yu.М. Stepanov, А.В. Саленко · 2021 · GASTROENTEROLOGY
  27. Prúrigo nodular de hyde como manifestación cutánea de la cirrosis biliar primaria: A propósito de un reporte de caso y breve revisión de la literatura
    Astrid Lorena Ruiz, Grégory Alfonso García Morán · 2017 · Revista Médica Sanitas
  28. Faculty Opinions recommendation of Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.
    Gustav Paumgartner · 2012 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  29. Cholestatic Diseases, Chronic
    Simon D. Hohenester, Gerald Denk · 2019 · Encyclopedia of Gastroenterology
  30. Terapias usuales y emergentes en colangitis biliar primaria
    Juan Camilo Díaz-Duque, Valeria Palacio-Valencia, Julissa Suárez-Meneses, Jesús Antonio Montaña-López, Eliana Palacio-Sánchez · 2022 · Hepatología
  31. Enfermedad hepática en la fibrosis quística pediátrica. Una revisión de los conocimientos actuales
    2023 · Archivos Argentinos de Pediatria
  32. Cholestatic diseases
    Guido Carpino, Ludovica Ceci, Lindsey Leann Kennedy, Eugenio Gaudio, Leonardo Baiocchi · 2024 · Elsevier eBooks
  33. Recommendations and quality criteria to improve the early diagnosis of primary biliary cholangitis
    Álvaro Díaz‐González, Noelia Fontanillas, Eva Gil-Hernández, Mercedes Guilabert, María‐Carlota Londoño, Mar Noguerol, Fernando Pérez Escanilla, José Joaquín Mira, Manel Santiñà · 2024 · Gastroenterología y Hepatología (English Edition)
  34. Primary biliary cholangitis, a rising health burden
    Mohamed Elnaggar, Ismail Elkhattib, Ahmed Abomhya, James Lorenzen Boyer · 2024 · Exploration of Immunology
  35. Diseases of the Biliary Tree
    Pierre Russo, Elizabeth B. Rand, Kathleen M. Loomes · 2024 · Springer eBooks
  36. Normothermic Regional Perfusion for Donation After Circulatory Death Liver Transplantation: State of the Art and a Biodesign Framework for Adoption
    Keith S. Hansen, Yanik J. Bababekov · 2025 · Current Transplantation Reports
  37. URSODEOKSİKOLİK ASİTİN FARMAKOLOJİSİ VE KLİNİK KULLANIMI
    Yunus Emre Başar, Ebru Yıldırım, Emine Baydan · 2025 · Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni
  38. Management and Modification of Flavonoids Against Nonalcoholic Fatty Liver Disease
    Weidong Bai, Bingqi Huang, Wenhong Zhao, Gongliang Liu, Limei Yu, Zhi Lü, Hong Wang · 2025 · Food Bioengineering
  39. Differenzialdiagnostik der Cholestase bei Erwachsenen
    Carola Dröge, Thomas Berg, Verena Keitel-Anselmino · 2025 · Gastroenterologie up2date
  40. Immunpathogenese und Therapie der Primär Sklerosierenden Cholangitis
    Britta Franziska Zecher, Christoph Schramm · 2026 · Zeitschrift für Gastroenterologie
  41. Alterations of bile acid composition in children with cystic fibrosis compared to healthy controls
    Felix Escher, Gerhard Liebisch, Michael Melter, Thomas S. Weiß, Birgit Knoppke, Alexander Kiefer · 2026 · Journal of Cystic Fibrosis
  42. Régulation des fonctions des myofibroblastes portaux par le stress du réticulum endoplasmique
    Emilien J. Loeuillard · 2017 · theses.fr (ABES)
  43. Interactions foie-intestin dans la cholangite sclérosante primitive
    Astrid Kemgang · 2019 · theses.fr (ABES)
  44. Impact hépatoprotecteur du récepteur TGR5 des acides biliaires : rôle central de la régulation des fonctions vésiculaires et de la composition du pool d’acides biliaires
    V. Bidault · 2021
  45. Influence of bile acids metabolism on hepatic immunity in mice
    Valentine Guinot · 2022 · theses.fr (ABES)
  46. Impact of cystic fibrosis transmembrane conductance regulator modulator therapies on liver stiffness and liver enzymes: An observational perspective single‐center cohort study
    Laura Giugliano, Elisabetta Augustoni, Antonio Pizzol, Anna Opramolla, Cristina Chiadò, Anna Zagaria, Iréne Esposito, Giulia Roberto, Alice Ponte, Andrea Evangelista et al. · 2026 · JPGN Reports
  47. The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study
    Bregje Mol, Kim N. van Munster, R Weersma, Akin Inderson, Kirsten Boonstra, Joost P.H. Drenth, Suzanne van Meer, Elsemieke de Vries, Marcel Spanier, Anton A. Vrij et al. · 2026 · Journal of Gastroenterology
  48. Carbonate alkalinity disrupts the bile acid liver-gut axis and impairs growth in Carassius auratus
    Yang Yang, Song Wu, Hongyu Cheng, Xiaofeng Jin, Qianwen Liu, Shijie You, Jing Wang, Yanchun Sun · 2026 · Water Biology and Security
  49. Orchestrated cell death pathways in cholangiopathies
    Maria Eugenia Guicciardi, Valéria Pistorio, Pierre‐Antoine Soret, Virginie Steunou, Gregory James Gores, Jérémie Gautheron · 2026 · Gut
  50. Heterozygous CFTR variants associated with low-phospholipid-associated cholelithiasis phenotypes expand hepatobiliary disorders spectrum
    Camille GIANNETTI, Louis Carmarans, Patrice Bourgeois, René Gerolami, Patrick Borentain, Diane Lorenzo, Solène Hoibian, Alexandre Fabre, Catherine Badens, Christophe Buffat · 2026 · Journal of Cystic Fibrosis